Safety Introducer Needle
FDA Clearance Information
The safety introducer needle was cleared by the FDA via the 510(k) pathway on July 15, 2003. Manufactured by B. Braun Medical, it is classified as a Class 2 device.
What It Is
FDA-Cleared Indications
- Facilitation of vascular access for the introduction of catheters and other intravascular devices.
- Use during procedures in which a needle is required to access a blood vessel.
Clinical Applications
- Obtaining percutaneous vascular access before catheter-based treatment.
- Introducing vascular catheters used for diagnostic angiography.
- Establishing access for endovascular procedures, including embolization and other catheter-directed treatments.
- Obtaining vascular access in hospital, intensive-care, surgical and interventional procedure settings.
Evidence Summary
Reported Outcomes
Safety Profile
Evidence Limitations
Practical Considerations
- The available needle size, length and configuration should match the target vessel, access technique and catheter or guidewire system.
- Use requires sterile technique and appropriate imaging or anatomic guidance to reduce bleeding, arterial injury and other access-site complications.
- Compatibility with the intended guidewire, catheter and introducer system should be confirmed before use.
- MRI safety depends on the specific needle and whether it remains in the patient; consult the current product labeling rather than assuming MRI compatibility.
- Potential complications include bleeding, hematoma, infection, vessel injury, pseudoaneurysm and accidental puncture of an adjacent structure.
Procedures that use this device
Frequently Asked Questions
What are the clinical indications for safety introducer needle?
The safety introducer needle is indicated for use in vascular access procedures, particularly for introducing catheters in embolization-coil placements.
What outcomes have been reported in clinical studies?
Studies report effective catheter placement with reduced risk of complications, highlighting the needle's precision in vascular access.
What complications have been reported?
Safety data indicate potential complications such as intravascular retention of fragments, particularly if the needle is reinserted improperly.